Treatment of superficial femoral artery occlusive disease

Journal of Cardiovascular Surgery

Volumn 45, Issue 3, 2004, Pages 193-201

  Dorrucci, V ^a,b  

^a Umberto I Hospital   (Italy)

^b NONE   (Italy)

Author keywords

Arterial occlusive diseases; Femoral artery; Peripheral vascular disease

Indexed keywords

ARTERY DISEASE; ARTERY GRAFT; ARTERY INTIMA; ARTERY PROSTHESIS; CALCULATION; CLINICAL FEATURE; CLINICAL STUDY; COMORBIDITY; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; HUMAN; INTERMETHOD COMPARISON; LANGUAGE; MAJOR CLINICAL STUDY; MEDICAL LITERATURE; PATIENT SELECTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; REVIEW; STENT; SUPERFICIAL FEMORAL ARTERY; SURGICAL TECHNIQUE; TREATMENT INDICATION; TREATMENT OUTCOME; VASCULAR PATENCY; VEIN BYPASS; AGED; ANGIOGRAPHY; BLOOD VESSEL PROSTHESIS; COMPARATIVE STUDY; ENDARTERECTOMY; FEMALE; FEMORAL ARTERY; HOSPITALIZATION; INSTRUMENTATION; MALE; METHODOLOGY; MIDDLE AGED; MINIMALLY INVASIVE SURGERY; PROGNOSIS; RADIOGRAPHY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; VASCULAR SURGERY;

AGED; ANGIOGRAPHY; ANGIOPLASTY, BALLOON; ARTERIAL OCCLUSIVE DISEASES; BLOOD VESSEL PROSTHESIS; ENDARTERECTOMY; FEMALE; FEMORAL ARTERY; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STENTS; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TREATMENT OUTCOME; VASCULAR SURGICAL PROCEDURES;

EID: 4043104218     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (112)

1. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Concensus (TASC). J Vasc Surg 2000;31(1 Pt 2):S1-S296.
2. Bergamini TM, Towne JB, Bandyk DF, Seabrook GR, Schmitt DD. Experience with in situ saphenous vein bypasses during 1981 to 1989: determinant factors of long-term patency. J Vasc Surg 1991;13:137-47; discussion 48-9.
3. Bergan JJ, Veith FJ, Bernhard VM, Yao JS, Flinn WR, Gupta SK et al. Randomization of autogenous vein and polytetrafluorethylene grafts in femoral-distal reconstruction. Surgery 1982;92:921-30.
4. Klinkert P, Schepers A, Burger DH, van Bockel JH, Breslau PJ. Vein versus polytetrafluoroethylene in above-knee femoropopliteal bypass grafting: five-year results of a randomized controlled trial. J Vasc Surg 2003;37:149-55.
5. Sala F, Hassen-Khodja R, Lecis A, Bouillanne PJ, Declemy S, Batt M. Long-term outcome of femoral above-knee popliteal artery bypass using autologous saphenous vein versus expanded polytetrafluoroethylene grafts. Ann Vasc Surg 2003;17:401-7.
6. Taylor LM Jr, Edwards JM, Porter JM. Present status of reversed vein bypass grafting: five-year results of a modern series. J Vasc Surg 1990;11:193-205; discussion 205-6.
7. Burger DH, Kappetein AP, Van Bockel JH, Breslau PJ. A prospective randomized trial comparing vein with polytetrafluoroethylene in above-knee femoropopliteal bypass grafting. J Vasc Surg 2000;32:278-83.
8. Faries PL, Logerfo FW, Arora S, Hook S, Pulling MC, Akbari CM et al. A comparative study of alternative conduits for lower extremity revascularization: all-autogenous conduit versus prosthetic grafts. J Vasc Surg 2000;32:1080-90.
9. Johnson WC, Lee KK. A comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous vein bypass grafts for femoral-popliteal above-knee revascularization: a prospective randomized Department of Veterans Affairs cooperative study. J Vasc Surg 2000;32:268-77.
10. Ballotta E, Renon L, Toffano M, Da Giau G. Prospective randomized study on bilateral above-knee femoropopliteal revascularization: polytetrafluoroethylene graft versus reversed saphenous vein. J Vasc Surg 2003;38:1051-5.
11. Blair JM, Gewertz BL, Moosa H, Lu CT, Zarins CK. Percutaneous transluminal angioplasty versus surgery for limb-threatening ischemia. J Vasc Surg 1989;9:698-703.
12. Jackson MR, Belott TP, Dickason T, Kaiser WJ, Modrall JG, Valentine RJ et al. The consequences of a failed femoropopliteal bypass grafting: comparison of saphenous vein and PTFE grafts. J Vasc Surg 2000;32:498-504;504-5.
13. Kent KC, Donaldson MC, Attinger CE, Couch NP, Mannick JA, Whittemore AD. Femoropopliteal reconstruction for claudication. The risk to life and limb. Arch Surg 1988;123:1196-8.
14. McCollum C, Kenchington G, Alexander C, Franks PJ, Greenhalgh RM. PTFE or HUV for femoro-popliteal bypass: a multi-centre trial. Eur J Vasc Surg 1991;5:435-43.
15. Veith FJ, Gupta SK, Ascer E, White-Flores S, Samson RH, Scher LA et al. Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions. J Vasc Surg 1986;3:104-14.
16. Wilson YG, Wyatt MG, Currie IC, Baird RN, Lamont PM. Preferential use of vein for above-knee femoropopliteal grafts. Eur J Vasc Endovasc Surg 1995;10:220-5.
17. AbuRahma AF, Robinson PA, Holt SM. Prospective controlled study of polytetrafluoroethylene versus saphenous vein in claudicant patients with bilateral above knee femoropopliteal bypasses. Surgery 1999;126:594-601; discussion 601-2.
18. Aalders GJ, van Vroonhoven TJ. Polytetrafluoroethylene versus human umbilical vein in above-knee femoropopliteal bypass: six-year results of a randomized clinical trial. J Vasc Surg 1992;16:816-23; discussion 23-4.
19. Allen BT, Reilly JM, Rubin BG, Thompson RW, Anderson CB, Flye MW et al. Femoropopliteal bypass for claudication: vein vs PTFE. Ann Vasc Surg 1996;10:178-85.
20. Charlesworth PM, Brewster DC, Darling RC, Robison JG, Hallet JW. The fate of polytetrafluoroethylene grafts in lower limb bypass surgery: a six year follow-up. Br J Surg 1985;72:896-9.
21. Devine C, Hons B, McCollum C. Heparin-bonded Dacron or polytetrafluoroethylene for femoropopliteal bypass grafting: a multicenter trial. J Vasc Surg 2001;33:533-9.
22. Evans LE, Webster MW, Brooks DH, Bahnson HT. Expanded polytetrafluoroethylene femoropopliteal grafts: forty-eight-month follow-up. Surgery 1981;89:16-22.
23. Green RM, Abbott WM, Matsumoto T, Wheeler JR, Miller N, Veith FJ et al. Prosthetic above-knee femoropopliteal bypass grafting: five-year results of a randomized trial. J Vasc Surg 2000;31:417-25.
24. Hobson RW 2nd, Lynch TG, Jamil Z, Karanfilian RG, Lee BC, Padberg FT Jr et al. Results of revascularization and amputation in severe lower extremity ischemia: a five-year clinical experience. J Vasc Surg 1985;2:174-85.
25. Gupta SK, Veith FJ, Kram HB, Wengerter KR. Prospective, randomized comparison of ringed and nonringed polytetrafluoroethylene femoropopliteal bypass grafts: a preliminary report. J Vasc Surg 1991;13:163-72.
26. McAuley CE, Steed DL, Webster MW. Seven-year follow-up of expanded polytetrafluoroethylene (PTFE) femoropopliteal bypass grafts. Ann Surg 1984;199:57-60.
27. O'Riordain DS, Buckley DJ, O'Donnell JA. Polytetrafluoroethylene in above-knee arterial bypass surgery for critical ischemia. Am J Surg 1992;164:129-31.
28. Patterson RB, Fowl RJ, Kempczinski RF, Gewirtz R, Shukla R. Preferential use of EPTFE for above-knee femoropopliteal bypass grafts. Ann Vasc Surg 1990;4:338-43.
29. Pevec WC, Darling RC, L'Italien GJ, Abbott WM. Femoropopliteal reconstruction with knitted, nonvelour Dacron versus expanded polytetrafluoroethylene. J Vasc Surg 1992;16:60-5.
30. Post S, Kraus T, Muller-Reinartz U, Weiss C, Kortmann H, Quentmeier A et al. Dacron vs polytetrafluoroethylene grafts for femoropopliteal bypass: a prospective randomised multicentre trial. Eur J Vasc Endovasc Surg 2001;22:226-31.
31. Prendiville EJ, Yeager A, O'Donnell TF Jr, Coleman JC, Jaworek A, Callow AD et al. Long-term results with the above-knee popliteal expanded polytetrafluoroethylene graft. J Vasc Surg 1990;11: 517-24.
32. Quinones-Baldrich WJ, Prego AA, Ucelay-Gomez R, Freischlag JA, Ahn SS, Baker JD et al. Long-term results of infrainguinal revascularization with polytetrafluoroethylene: a ten-year experience. J Vasc Surg 1992;16:209-17.
33. Robinson BI, Fletcher JP, Tomlinson P, Allen RD, Hazelton SJ, Richardson AJ et al. A prospective randomized multicentre comparison of expanded polytetrafluoroethylene and gelatin-sealed knitted Dacron grafts for femoropopliteal bypass. Cardiovasc Surg 1999;7:214-8.
34. Rosenthal D, Evans RD, McKinsey J, Seagraves MA, Lamis PA, Clark MD et al. Prosthetic above-knee femoropopliteal bypass for intermittent claudication. J Cardiovasc Surg (Torino) 1990;31: 462-8.
35. Rutherford RB, Jones DN, Bergentz SE, Bergqvist D, Comerota AJ, Dardik H et al. Factors affecting the patency of infrainguinal bypass. J Vasc Surg 1988;8:236-46.
36. Sterpetti AV, Schultz RD, Feldhaus RJ, Peetz DJ Jr. Seven-year experience with polytetrafluoroethylene as above-knee femoropopliteal bypass graft. Is is worthwhile to preserve the autologous saphenous vein? J Vasc Surg 1985;2:907-12.
37. Tilanus HW, Obertop H, Van Urk H. Saphenous vein or PTFE for femoropopliteal bypass. A prospective randomized trial. Ann Surg 1985;202:780-2.
38. Whittemore AD, Kent KC, Donaldson MC, Couch NP, Mannick JA. What is the proper role of polytetrafluoroethylene grafts in infrainguinal reconstruction? J Vasc Surg 1989;10:299-305.
39. Woratyla SP, Darling RC 3rd, Chang BB, Paty PS, Kreienberg PB, Leather RP et al. The performance of femoropopliteal bypasses using polytetrafluoroethylene above the knee versus autogenous vein below the knee. Am J Surg 1997;174:169-72.
40. el-Massry S, Saad E, Sauvage LR, Zammit M, Smith JC, Davis CC et al. Femoropopliteal bypass with externally supported knitted Dacron grafts: a follow-up of 200 grafts for one to twelve years. J Vasc Surg 1994;19:487-94.
41. Kremen AF, Mendez-Fernandez MA, Geis RC, Henly WS. The Dacron EXS graft: patency in femoropopliteal and femorotibial surgery. J Cardiovasc Surg (Torino) 1986;27:125-30.
42. Matsubara J, Nagasue M, Tsuchishima S, Nakatani B, Shimizu T. Clinical results of femoropopliteal bypass using externally supported (EXS) Dacron grafts: with a comparison of above- and below-knee anastomosis. J Cardiovasc Surg (Torino) 1990;31:731-4.
43. Mosley JG, Marston A. A 5 year follow-up of Dacron femoropopliteal bypass grafts. Br J Surg 1986;73:24-7.
44. Maynar M, Reyes R, Ferral H, Gorriz E, Gomez-Toledo F, de Blas M et al. Cragg Endopro System I: early experience. I. Femoral arteries. J Vasc Interv Radiol 1997;8:203-7.
45. Ahmadi R, Schillinger M, Maca T, Minar E. Femoropopliteal arteries: immediate and long-term results with a Dacron-covered stent-graft. Radiology 2002;223:345-50.
46. Henry M, Amor M, Cragg A, Porte JM, Henry I, Amicabile C et al. Occlusive and aneurysmal peripheral arterial disease: assessment of a stent-graft system. Radiology 1996;201:717-24.
47. Kessel DO, Wijesinghe LD, Robertson I, Scott DJ, Raat H, Stockx L et al. Endovascular stent-grafts for superficial femoral artery disease: results of 1-year follow-up. J Vasc Interv Radiol 1999;10: 289-96.
48. Rodriguez-Lopez JA, Soler L, Werner A, Martinez E, Papazoglou K, Diethrich EB. Long-term follow-up of endoluminal grafting for aneurysmal and occlusive disease in the superficial femoral artery. J Endovasc Surg 1999;6:270-7.
49. Spoelstra H, Casselman F, Lesceu O. Balloon-expandable endobypass for femoropopliteal atherosclerotic occlusive disease. A preliminary evaluation of fifty-five patients. J Vasc Surg 1996;24: 647-54.
50. Bauermeister G. Endovascular stent-grafting in the treatment of superficial femoral artery occlusive disease. J Endovasc Ther 2001;8:315-20.
51. Bray PJ, Robson WJ, Bray AE. Percutaneous treatment of long superficial femoral artery occlusive disease: efficacy of the Hemobahn stent-graft. J Endovasc Ther 2003;10:619-28.
52. Jahnke T, Andresen R, Muller-Hulsbeck S, Schafer FK, Voshage G, Heller M et al. Hemobahn stent-grafts for treatment of femoropopliteal arterial obstructions: midterm results of a prospective trial. J Vasc Interv Radiol 2003;14:41-51.
53. Deutschmann HA, Schedlbauer P, Berczi V, Portugaller H, Tauss J, Hausegger KA. Placement of Hemobahn stent-grafts in femoropopliteal arteries: early experience and midterm results in 18 patients. J Vasc Interv Radiol 2001;12:943-50.
54. Fischer M, Langhoff R, Schulte KL. [Hemobahn-endoprosthesis: long-term experience (< or = 4 years follow-up) with percutaneous application in stenoses and occlusions of the superficial femoral artery]. Zentralbl Chir 2003;128:740-5.
55. Lammer J, Dake MD, Bleyn J, Katzen BT, Cejna M, Piquet P et al. Peripheral arterial obstruction: prospective study of treatment with a transluminally placed self-expanding stent-graft. International Trial Study Group. Radiology 2000;217:95-104.
56. Railo M, Roth WD, Edgren J, Biancari F, Ikonen T, Alback A et al. Preliminary results with endoluminal femoropopliteal thrupass. Ann Chir Gynaecol 2001;90:15-8.
57. Saxon RR, Coffman JM, Gooding JM, Ponce DJ. Stent-graft use in the femoral and popliteal arteries. Tech Vasc Intervent Radiol 2004;7:6-15.
58. Turicchia GU, Cevolani M, Altini R, Stancanelli V. Mid-term results in PTFE endograft treatment of femoropopliteal occlusive disease. Osp Ital Chir 2003;9:93-6.
59. Vroegindeweij D, Vos LD, Tielbeek AV, Buth J, vd Bosch HC. Balloon angioplasty combined with primary stenting vetsus balloon angioplasty alone in femoropopliteal obstructions: a comparative randomized study. Cardiovasc Intervent Radiol 1997;20:420-5.
60. Wolosker N, Nakano L, Anacleto MM, Puech-Leao P. Primary utilization of stents in angioplasty of superficial femoral artery. Vasc Endovascular Surg 2003;37:271-7.
61. Bergeron P, Pinot JJ, Poyen V, Benichou H, Khanoyan P, Rudondy P et al. Long-term results with the Palmaz stent in the superficial femoral artery. J Endovasc Surg 1995;2:161-7.
62. Cejna M, Thurnher S, Illiasch H, Horvath W, Waldenberger P, Hornik K et al. PTA versus Palmaz stent placement in femoropopliteal artery obstructions: a multicenter prospective randomized study. J Vasc Interv Rachel 2001;12:23-31.
63. Chatelard P, Guibourt Z. Long-term results with a Palmaz stent in the femoropopliteal arteries. J Cardiovasc Surg (Torino) 1996;37(3 Suppl 1):67-72.
64. Gray BH, Sullivan TM, Childs MB, Young JR, Olin JW. High incidence of restenosis/reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty. J Vasc Surg 1997;25:7443.
65. Grimm J, Muller-Hulsbeck S, Jahnke T, Hilbert C, Brossmann J, Heller M. Randomized study to compare PTA alone versus PTA with Palmaz stent placement for femoropopliteal lesions. J Vasc Interv Radiol 2001;12:935-42.
66. Henry M, Amor M, Ethevenot G, Henry I, Amicabile C, Beron R et al. Palmaz stent placement in iliac and femoropopliteal arteries: primary and secondary patency in 310 patients with 2-4-year follow-up. Radiology 1995;197:167-74.
67. Liermann D, Strecker EP, Peters J. The Strecker stent: indications and results in iliac and femoropopliteal arteries. Cardiovasc Intervent Radiol 1992;15:298-305.
68. White GH, Liew SC, Waugh RC, Stephen MS, Harris JP, Kidd J et al. Early outcome and intermediate follow-up of vascular stents in the femoral and popliteal arteries without long-term anticoagulation. J Vasc Surg 1995;21:270-9; discussion 279-81.
69. Zdanowski Z, Albrechtsson U, Lundin A, Jonung T, Ribbe E, Thorne J et al. Percutaneous transluminal angioplasty with or without stenting for femoropopliteal occlusions? A randomized controlled study. Int Angiol 1999;18:251-5.
70. Cheng SW, Ting AC, Wong J. Endovascular stenting of superficial femoral artery stenosis and occlusions: results and risk factor analysis. Cardiovasc Surg 2001;9:133-40.
71. Do dai D, Triller J, Walpoth BH, Stirnemann P, Mahler F. A comparison study of self-expandable stents vs balloon angioplasty alone in femoropopliteal artery occlusions. Cardiovasc Intervent Radiol 1992;15:306-12.
72. Gordon IL, Conroy RM, Arefi M, Tobis JM, Stemmer EA, Wilson SE. Three-year outcome of endovascular treatment of superficial femoral artery occlusion. Arch Surg 2001;136:221-8.
73. Martin EC, Katzen BT, Benenati JF, Diethrich EB, Dorros G, Graor RA et al. Multicenter trial of the wallstent in the iliac and femoral arteries. J Vasc Interv Radiol 1995;6:843-9.
74. Rousseau HP, Raillat CR, Joffre FG, Knight CJ, Ginestet MC. Treatment of femoropopliteal stenoses by means of self-expandable endoprostheses: midterm results. Radiology 1989;172(3 Pt 2):961-4.
75. Sapoval MR, Long AL, Raynaud AC, Beyssen BM, Fiessinger JN, Gaux JC. Femoropopliteal stent placement: long-term results. Radiology 1992;184:833-9.
76. Schillinger M, Mlekusch W, Haumer M, Sabeti S, Ahmach R, Minar E. Angioplasty and elective stenting of de novo versus recurrent femoropopliteal lesions: 1-year follow-up. J Endovasc Ther 2003;10:288-97.
77. Zollikofer CL, Antonucci F, Pfyffer M, Redha F, Salomonowitz E, Stuckmann G et al. Arterial stent placement with use of the Wallstent: midterm results of clinical experience. Radiology 1991;179:449-56.
78. Vogel TR, Shindelman LE, Nackman GB, Graham AM. Efficacious use of nitinol stents in the femoral and popliteal arteries. J Vasc Surg 2003;38:1178-84.
79. Henry M, Amor M, Beyar R, Henry I, Porte JM, Mentre B et al. Clinical experience with a new nitinol self-expanding stent in peripheral arteries. J Endovasc Surg 1996;3:369-79.
80. Jahnke T, Voshage G, Muller-Hulsbeck S, Grimm J, Heller M, Brossmann J. Endovascular placement of self-expanding nitinol coil stents for the treatment of femoropopliteal obstructive disease. J Vasc Interv Radiol 2002;13:257-66.
81. Duda SH, Pusich B, Richter G, Landwehr P, Oliva VL, Tielbeek A et al. Sirolimus-eluting stems for the treatment of obstructive superficial femoral artery disease: six-month results. Circulation 2002;106:1505-9.
82. Lugmayr HF, Holzer H, Kastner M, Riedelsberger H, Auterith A. Treatment of complex arteriosclerotic lesions with nitinol stents in the superficial femoral and popliteal arteries: a midterm follow-up. Radiology 2002;222:37-43.
83. Martin DR, Katz SG, Kohl RD, Qian D. Percutaneous transluminal angioplasty of infrainguinal vessels. Ann Vasc Surg 1999;13:184-7.
84. Matsi PJ, Manninen HI, Vanninen RL, Suhonen MT, Oksala I, Laakso M et al. Femoropopliteal angioplasty in patients with claudication: primary and secondary patency in 140 limbs with 1-3-year follow-up. Radiology 1994;191:727-33.
85. Becquemin JP, Cavillon A, Haiduc F. Surgical transluminal femoropopliteal angioplasty: multivariate analysis outcome. J Vasc Surg 1994;19:495-502.
86. Lofberg AM, Karacagil S, Ljungman C, Westman B, Bostrom A, Hellberg A et al. Percutaneous transluminal angioplasty of the femoropopliteal arteries in limbs with chronic critical lower limb ischemia. J Vasc Surg 2001;34:114-21.
87. Murray JG, Apthorp LA, Wilkins RA. Long-segment (> or = 10 cm) femoropopliteal angioplasty: improved technical success and long-term patency. Radiology 1995;195:158-62.
88. Capek P, McLean GK, Berkowitz HD. Femoropopliteal angioplasty. Factors influencing long-term success. Circulation 1991;83(2 Suppl):170-80.
89. Golledge J, Ferguson K, Ellis M, Sabharwal T, Davies AH, Greenhalgh RM et al. Outcome of femoropopliteal angioplasty. Ann Surg 1999;229:146-53.
90. Jamsen TS, Manninen HI, Jaakkola PA, Matsi FJ. Long-term outcome of patients with claudication after balloon angioplasty of the femoropopliteal arteries. Radiology 2002;225:345-52.
91. Jeans WD, Cole SE, Horrocks M, Baird RN. Angioplasty gives good results in critical lower limb ischaemia. A 5-year follow-up in patients with known ankle pressure and diabetic status having femoropopliteal dilations. Br J Radiol 1994;67:123-8.
92. Kalman PG, Johnston KW, Sniderman KW. Indications and results of balloon angioplasty for arterial occlusive lesions. World J Surg 1996;20:630-4.
93. Karch LA, Mattos MA, Henretta JP, McLafferty RB, Ramsey DE, Hodgson KJ. Clinical failure after percutaneous transluminal angioplasty of the superficial femoral and popliteal arteries. J Vasc Surg 2000;31:880-7.
94. O'Donohoe MK, Sultan S, Colgan MP, Moore DJ, Shanik GD. Outcome of the first 100 femoropopliteal angioplasties performed in the operating theatre. Eur J Vasc Endovasc Surg 1999;17:66-71.
95. Parsons RE, Suggs WD, Lee JJ, Sanchez LA, Lyon RT, Veith FJ. Percutaneous transluminal angioplasty for the treatment of limb threatening ischemia: do the results justify an attempt before bypass grafting? J Vasc Surg 1998;28:1066-71.
96. Pozzi Mucelli F, Fisicaro M, Calderan L, Calderan L, Malacrea M, Mazzone C et al. Percutaneous revascularization of femoropopliteal artery disease: PTA and PTA plus stent. Results after six years' follow-up. Radiol Med (Torino) 2003;105:339-49.
97. Stanley B, Teague B, Raptis S, Taylor DJ, Berce M. Efficacy of balloon angioplasty of the superficial femoral artery and popliteal artery in the relief of leg ischemia. J Vasc Surg 1996;23:679-85.
98. Tielbeek AV, Vroegindeweij D, Buth J, Landman CH. Comparison of balloon angioplasty and Simpson atherectomy for lesions in the femoropopliteal artery: angiographic and clinical results of a prospective randomized trial. J Vasc Interv Radiol 1996;7:837-44.
99. Treiman GS, Ichikawa L, Treiman RL, Landman CH. Treatment of recurrent femoral or popliteal artery stenosis after percutaneous transluminal angioplasty. J Vasc Surg 1994;20:577-85; discussion 85-7.
100. Vroegindeweij D, Tielbeek AV, Buth J, van Kints MJ, Landman GH, Mali WP. Recanalization of femoropopliteal occlusive lesions: a comparison of long-term clinical, color duplex US, and arteriographic follow-up. J Vasc Interv Radiol 1995;6:331-7.
101. London NJ, Srinivasan R, Naylor AR, Hartshorne T, Ratliff DA, Bell PR et al. Subintimal angioplasty of femoropopliteal artery occlusions: the long-term results. Eur J Vasc Surg 1994;8:148-55.
102. Berengoltz-Zlochin SN, Mali WP, Borst C, van der Tweel I, Robles de Medina EO. Subintimal versus intraluminal laser-assisted recanalization of occluded femoropopliteal arteries: one-year clinical and angiographic follow-up. J Vasc Interv Radiol 1994;5:689-96.
103. Laxdal E, Jenssen GL, Pedersen G, Aune S. Subintimal angioplasty as a treatment of femoropopliteal artery occlusions. Eur J Vasc Endovasc Surg 2003;25:578-82.
104. Lipsitz EC, Ohki T, Veith FJ, Suggs WD, Wain RA, Cynamon J et al. Does subintimal angioplasty have a role in the treatment of severe lower extremity ischemia? J Vasc Surg 2003;37:386-91.
105. McCarthy RJ, Neary W, Roobottom C, Tottle A, Ashley S. Short-term results of femoropopliteal subintimal angioplasty. Br J Surg 2000;87:1361-5.
106. Nydahl S, Hartshorne T, Bell PR, Bolia A, London NJ. Subintimal angioplasty of infrapopliteal occlusions in critically ischaemic limbs. Eur J Vasc Endovasc Surg 1997;14:212-6.
107. Reekers JA, Kromhout JG, Jacobs MJ. Percutaneous intentional extraluminal recanalisation of the femoropopliteal artery. Eur J Vasc Surg 1994;8:723-8.
108. Shaw MB, DeNunzio M, Hinwood D, Nash R, Callum KG, Braithwaite BD. The results of subintimal angioplasty in a district general hospital. Eur J Vasc Endovasc Surg 2002;24:524-7.
109. Tisi PV, Mirnezami A, Baker S, Tawn J, Parvin SD, Darke SG. Role of subintimal angioplasty in the treatment of chronic lower limb ischaemia. Eur J Vasc Endovasc Surg 2002;24: 417-22.
110. Treiman GS, Whiting JH, Treiman RL, McNamara RM, Ashrafi A. Treatment of limb-threatening ischemia with percutaneous intentional extraluminal recanalization: a preliminary evaluation. J Vasc Surg 2003;38:29-35.
111. Yilmaz S, Sindel T, Yegin A, Luleci E. Subintimal angioplasty of long superficial femoral artery occlusions. J Vasc Interv Radiol 2003;14:997-1010.
112. Yilmaz S, Sindel T, Ceken K, Ajimoglu E, Luleci E. Subintimal recanalization of long superficial femoral artery occlusions through the retrograde popliteal approach. Cardiovasc Intervent Radiol 2001;24:154-60.